Rockefeller Capital Management
BNTX icon

Rockefeller Capital Management’s BioNTech BNTX Stock Holding History

Rockefeller Capital Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$184K Sell
1,972
-16
-0.8% -$1.51K ﹤0.01% 2642
2026
Q1 		$177K Buy
1,988
+132
+7% +$13.6K ﹤0.01% 2573
2025
Q4 		$177K Buy
1,856
+1,423
+329% +$143K ﹤0.01% 2438
2025
Q3 		$42.8K Buy
+433
New +$46.3K ﹤0.01% 2987
2023
Q2 		– Sell
-1,713
Closed -$212K – 1833
2023
Q1 		$212K Sell
1,713
-37
-2% -$5.08K ﹤0.01% 1786
2022
Q4 		$262K Sell
1,750
-14
-0.8% -$2.15K ﹤0.01% 1539
2022
Q3 		$237K Buy
1,764
+29
+2% +$4.43K ﹤0.01% 1568
2022
Q2 		$258K Sell
1,735
-4,081
-70% -$624K ﹤0.01% 1527
2022
Q1 		$991K Buy
5,816
+836
+17% +$140K ﹤0.01% 1055
2021
Q4 		$1.28M Buy
4,980
+3,915
+368% +$1.07M 0.01% 964
2021
Q3 		$289K Buy
1,065
+104
+11% +$33.1K ﹤0.01% 1457
2021
Q2 		$214K Buy
961
+2
+0.2% +$377 ﹤0.01% 1486
2021
Q1 		$103K Buy
959
+896
+1,422% +$95.2K ﹤0.01% 1582
2020
Q4 		$5K Hold
63
– – ﹤0.01% 2418
2020
Q3 		$4K Hold
63
– – ﹤0.01% 2264
2020
Q2 		$4K Buy
+63
New +$3.15K ﹤0.01% 2139

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Rockefeller Capital Management's BNTX Position: Q2 2026 in Review

Rockefeller Capital Management reduced its BioNTech (BNTX) stake by 0.8% in Q2 2026, selling an estimated $1.51K and leaving 1,972 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #2642.

Rockefeller Capital Management first reported a position in BNTX in Q2 2020 and has held it in 16 quarters since. The position peaked at $1.28M in Q4 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Rockefeller Capital Management held 1,972 shares of BioNTech worth $184K as of Q2 2026.
  • Rockefeller Capital Management sold 16 BioNTech shares in Q2 2026, an estimated $1.51K.
  • BioNTech made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #2642 holding.
  • Rockefeller Capital Management first reported a position in BioNTech in Q2 2020 and has held it in 16 quarters since.
  • Rockefeller Capital Management's BioNTech position peaked at $1.28M in Q4 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.